Safety and efficacy of the farnesoid X receptor (FXR) agonist cilofexor in a proof-of-concept study in patients with compensated cirrhosis due to primary sclerosing cholangitis (PSC)

Journal article

Peer reviewed

Cynthia Levy, Stephen Caldwell, Parvez Mantry, Velimir Luketic, Charles Landis, Jonathan Huang, Edward Mena, Rahul Maheshwari, Kevin Rank, Jun Xu, …

Journal of hepatology, Vol.77, pp.S319-S320

07/2022

Metrics

1 Record Views

Title: Safety and efficacy of the farnesoid X receptor (FXR) agonist cilofexor in a proof-of-concept study in patients with compensated cirrhosis due to primary sclerosing cholangitis (PSC)
Creators: Cynthia Levy
Stephen Caldwell
Parvez Mantry
Velimir Luketic
Charles Landis
Jonathan Huang
Edward Mena
Rahul Maheshwari
Kevin Rank
Jun Xu
Xiangyu Lu
Xiaomin Lu
Chuhan Chung
Robert Myers
Kris Kowdley
Publication Details: Journal of hepatology, Vol.77, pp.S319-S320
Identifiers: 991006030870502656
Academic Unit: Internal Medicine
Language: English
Resource Type: Journal article